Doctor Sander van Doorn
University Medical Center Utrecht, Utrecht (Netherlands (The))
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Quality of life when switching from a vitamin K antagonist to non-vitamin K antagonist oral anticoagulation in frail older patients with atrial fibrillation
Event: EHRA 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Atrial fibrillation: clinical 1
Predicting bleeding risk in frail older patients with atrial fibrillation using data from the FRAIL-AF trial
Event: EHRA 2024
Topic: Oral Anticoagulation
Session: Atrial fibrillation: treatment 1
Effectiveness of CHA2DS2-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomized trial in general practice
Event: EuroPrevent 2018
Topic: Atrial Fibrillation, Other
Session: Moderated Poster Session IV
Predictive performance of the CHA2DS2-VASc rule in atrial fibrillation: a systematic review and meta-analysis
Event: EuroPrevent 2018
Topic: Atrial Fibrillation, Other
Session: Arrhythmias and device therapy
ESC 365 is supported by
